Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	2245.40	-244.08	10.41
Graham Fair Price	5.64	3.64	3.45
PEG	-76.36	0.02	-0.09
Price/Book	2.09	1.15	1.12
Price/Cash Flow	-22.22	-19.71	-16.12
Prices/Earnings	-19.39	-4.40	5.45
Price/Sales	50.55	3.88	2.58
Price/FCF	-22.22	-19.71	-16.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-89.10	0.04	0.37
Operating Margin	116.39	-0.26	0.12
ROA	17.26	-0.03	0.03
ROE	0.05	-0.07	26.64
ROIC	0.05	-0.06	23.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.32	0.50	-35.47
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.67	-2.38	-254.45
EPS QOQ	-0.64	-2.18	-240.98
FCF QOQ	0.59	0.22	-63.11
Revenue QOQ	0.51	-0.36	-28.52
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.21	8.30	33.69
Days Sales Outstanding (DSO)	46.49	90.15	93.91
Inventory Turnover	14.50	10.85	-25.20
Debt/Capitalization	0.09	0.13	44.27
Quick Ratio	0.43	0.45	4.43
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	3.20	3.00	-6.13
Cash	0.03	0.02	-43.04
Capex	-0.11	-0.15	-33.73
Free Cash Flow	-0.22	-0.18	21.59
Revenue	1.40	0.89	-36.34
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.55	0.57	3.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.98	-31.70	3143.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating